Curcumin prevents human dendritic cell response to immune stimulants

Biochemical and Biophysical Research Communications

Volumn 374, Issue 3, 2008, Pages 431-436

  Shirley, Shawna A ^a   Montpetit, Alison J ^b   Lockey, R F ^a   Mohapatra, Shyam S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Curcumin; Dendritic cells; Immunosuppression

Indexed keywords

CD14 ANTIGEN; CHEMOKINE; CURCUMIN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSTIMULATING AGENT; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID;

ADULT; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL MOVEMENT; CHEMOKINES; CURCUMIN; DENDRITIC CELLS; ENDOCYTOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; POLY I-C;

BACTERIA (MICROORGANISMS); CURCUMA LONGA;

EID: 49049100633     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.051     Document Type: Article

References (35)

1. Grant K.L., and Schneider C.D. Turmeric. Am. J. Health Syst. Pharm. 57 (2000) 1121-1122
2. Aggarwal B.B., Sundaram C., Malani N., and Ichikawa H. Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595 (2007) 1-75
3. Araujo C.C., and Leon L.L. Biological activities of Curcuma longa L. Mem. Inst. Oswaldo Cruz 96 (2001) 723-728
4. Kutluay S.B., Doroghazi J., Roemer M.E., and Triezenberg S.J. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology 373 (2008) 239-247
5. Mazumder A., Raghavan K., Weinstein J., Kohn K.W., and Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem. Pharmacol. 49 (1995) 1165-1170
6. Maheshwari R.K., Singh A.K., Gaddipati J., and Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 78 (2006) 2081-2087
7. Ammon H.P., Safayhi H., Mack T., and Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J. Ethnopharmacol. 38 (1993) 113-119
8. Xu Y.X., Pindolia K.R., Janakiraman N., Noth C.J., Chapman R.A., and Gautam S.C. Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. Exp. Hematol. 25 (1997) 413-422
9. Lantz R.C., Chen G.J., Solyom A.M., Jolad S.D., and Timmermann B.N. The effect of turmeric extracts on inflammatory mediator production. Phytomedicine 12 (2005) 445-452
10. Kohli K., Ali J., Ansari M.J., and Raheman Z. Curcumin: a natural antiinflammatory agent. Indian J. Pharmacol. 37 (2005) 141-147
11. Gradisar H., Keber M.M., Pristovsek P., and Jerala R. MD-2 as the target of curcumin in the inhibition of response to LPS. J. Leukoc. Biol. (2007)
12. Guermonprez P., Valladeau J., Zitvogel L., Thery C., and Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20 (2002) 621-667
13. Steinman R.M., and Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99 (2002) 351-358
14. Kim G.Y., Kim K.H., Lee S.H., Yoon M.S., Lee H.J., Moon D.O., Lee C.M., Ahn S.C., Park Y.C., and Park Y.M. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J. Immunol. 174 (2005) 8116-8124
15. + monocytes. In: Robinson S.P., Stagg A.J., and Knight S.C. (Eds). Dendritic Cell Protocols (2001), Humana Press Inc., Totowa, NJ 283-291
16. Sharma R.A., Steward W.P., and Gescher A.J. Pharmacokinetics and pharmacodynamics of curcumin. Adv. Exp. Med. Biol. 595 (2007) 453-470
17. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., and Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64 (1998) 353-356
18. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., and Maitra A. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J. Nanobiotechnol. 5 (2007) 3
19. Tiyaboonchai W., Tungpradit W., and Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337 (2007) 299-306
20. Weber W.M., Hunsaker L.A., Roybal C.N., Bobrovnikova-Marjon E.V., Abcouwer S.F., Royer R.E., Deck L.M., and Vander Jagt D.L. Activation of NFkappaB is inhibited by curcumin and related enones. Bioorg. Med. Chem. 14 (2006) 2450-2461
21. Huang T.S., Lee S.C., and Lin J.K. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 88 (1991) 5292-5296
22. Tang X., Marciano D.L., Leeman S.E., and Amar S. LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc. Natl. Acad. Sci. USA 102 (2005) 5132-5137
23. Reimer T., Brcic M., Schweizer M., and Jungi T.W. poly(I:C) and LPS induce distinct IRF3 and NF-kappaB signaling during type-I IFN and TNF responses in human macrophages. J. Leukoc. Biol. 83 (2008) 1249-1257
24. Sikora E., Bielak-Zmijewska A., Piwocka K., Skierski J., and Radziszewska E. Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem. Pharmacol. 54 (1997) 899-907
25. Huang H.C., Jan T.R., and Yeh S.F. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur. J. Pharmacol. 221 (1992) 381-384
26. Gao X., Kuo J., Jiang H., Deeb D., Liu Y., Divine G., Chapman R.A., Dulchavsky S.A., and Gautam S.C. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem. Pharmacol. 68 (2004) 51-61
27. Yadav V.S., Mishra K.P., Singh D.P., Mehrotra S., and Singh V.K. Immunomodulatory effects of curcumin. Immunopharmacol. Immunotoxicol. 27 (2005) 485-497
28. Benvenuti F., Hugues S., Walmsley M., Ruf S., Fetler L., Popoff M., Tybulewicz V.L., and Amigorena S. Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming. Science 305 (2004) 1150-1153
29. Holy J. Curcumin inhibits cell motility and alters microfilament organization and function in prostate cancer cells. Cell Motil. Cytoskeleton 58 (2004) 253-268
30. Gautam S.C., Gao X., and Dulchavsky S. Immunomodulation by curcumin. Adv. Exp. Med. Biol. 595 (2007) 321-341
31. Delemarre F.G., Hoogeveen P.G., De Haan-Meulman M., Simons P.J., and Drexhage H.A. Homotypic cluster formation of dendritic cells, a close correlate of their state of maturation. Defects in the biobreeding diabetes-prone rat. J. Leukoc. Biol. 69 (2001) 373-380
32. Sligh Jr. J.E., Ballantyne C.M., Rich S.S., Hawkins H.K., Smith C.W., Bradley A., and Beaudet A.L. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 90 (1993) 8529-8533
33. Gaglia J.L., Greenfield E.A., Mattoo A., Sharpe A.H., Freeman G.J., and Kuchroo V.K. Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells. J. Immunol. 165 (2000) 6091-6098
34. Nicolaou F., Teodoridis J.M., Park H., Georgakis A., Farokhzad O.C., Bottinger E.P., Da Silva N., Rousselot P., Chomienne C., Ferenczi K., Arnaout M.A., and Shelley C.S. CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD. Blood 101 (2003) 4033-4041
35. Lin C.L., Suri R.M., Rahdon R.A., Austyn J.M., and Roake J.A. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur. J. Immunol. 28 (1998) 4114-4122